Company intelligence / Profile preview

Venova Medical

Los Gatos, California, United Statesvenovamedical.com ↗

Ownership: Private
Development stage: Phase 1

Overview

Venova Medical has developed the Velocity pAVF System, a next-generation minimally invasive device for creating arteriovenous fistulas in patients needing hemodialysis. The first-in-human VENOS‑1 study demonstrated 100% technical success and rapid maturation of AVFs by 6 weeks. The company recently completed enrollment in the U.S.-based VENOS‑2 IDE early feasibility study and is preparing for a pivotal trial to support FDA approval.

Therapeutic areas: Nephrology
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Venova Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Venova Medical.

Explore the full profile